Use of coagulation factor VII - activating protease for the prophylaxis and therapy of vasoproliferative disorders

Details for Australian Patent Application No. 2002301208 (hide)

Owner Aventis Behring GmbH

Inventors Kanse, Sandip; Preissner, Klaus T.; Roemisch, Juergen; Kannemeier, Christian

Agent Watermark

Pub. Number AU-A-2002301208

Priority 101 48 037.7 28.09.01 DE

Filing date 26 September 2002

Wipo publication date 12 June 2003

International Classifications

A61K 038/48 Medicinal preparations containing peptides

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

12 June 2003 Application Open to Public Inspection

  Published as AU-A-2002301208

17 March 2005 Change of Name(s) of Applicant(s), Section 104

  Aventis Behring GmbH, The name of the applicant has been changed to ZLB Behring GmbH Change of Name(s) of Applicant(s), Section 104

23 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301209-Sealing Device

2002301207-Antiviral protease inhibitors